Two Decades of TB Drug Discovery Efforts—What Have We Learned?
After several years of limited success, an effective regimen for the treatment of both drug-sensitive and multiple-drug-resistant tuberculosis is in place. However, this success is still incomplete, as we need several more novel combinations to treat extensively drug-resistant tuberculosis, as well...
Main Authors: | Balachandra Bandodkar, Radha Krishan Shandil, Jagadeesh Bhat, Tanjore S. Balganesh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/16/5704 |
Similar Items
-
Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular Mycobacterium tuberculosis
by: Samuel Njikan, et al.
Published: (2022-06-01) -
Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery
by: Michela Guida, et al.
Published: (2024-05-01) -
Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection
by: Christian Shleider Carnero Canales, et al.
Published: (2023-09-01) -
Tuberculosis drug discovery in the post‐post‐genomic era
by: Benoit Lechartier, et al.
Published: (2014-01-01) -
Identification of Mycobacterium tuberculosis BioA inhibitors by using structure-based virtual screening
by: Singh S, et al.
Published: (2018-05-01)